Country:China>Guangdong>Zhuhai
No.5002 South Nanwan Road,Xiangzhou District
Company:Zhuhai Wumei Technology
Mobile:+86 17707567455
Tell0756-8811069
Erlotinib hydrochloride Synonyms: ERLOTINIB HCL;ERLOTINIB HCL SALT;ERLOTINIB HCL SALT :TARCEVA;Erlotinib, Hydrochloride Salt; CAS: *-69-9 MF: C22H24ClN3O4 MW: 429.9 EINECS: Product Categories: API;Molecular Targeted Antineoplastic;Heterocyclic Compounds;anti-neoplastic;Heterocycles;Intermediates & Fine Chemicals;Pharmaceuticals;Tarceva;Antineoplastic;Anti-cancer&immunity;Inhibitors. Indications and Usage Erlotinib hydrochlorate is a small molecule tyrosine kinase inhibitor which acts reversibly on epidermal growth factor receptors, a hydrochloride of erlotinib, a molecular-targeted drug. The US Food and Drug Administration (FDA) has approved erlotinib (Tarceva) combined with gemcitabine as a first-line treatment for locally advanced and metastatic pancreatic cancer. It is mainly used as a second- or third-line treatment for locally advanced or metstatic non-small cell lung cancer (NSCLC) and as a treatment for pancreatic cancer. It is used as a tyrosine inhibitor for NSCLC treatment
Avoid fraud by meeting all sellers in-person to pay for items. BestB2B.COM does not offer any transaction or payment services.